Patients can digitally record benefits and side effects

The Munich-based start-up XO Life (formerly Medikura) has developed an innovative digital platform that revolutionizes the monitoring of drug effectiveness and safety. The “ImpactMonitor” enables patients to digitally document treatment processes and relevant side effects. This data, including quality of life information, is systematically collected, pseudonymized and prepared for pharmaceutical companies and research institutes. They can use the data to improve pharmacovigilance and meet legal requirements.
Would you like to find out more or are you interested in XO Life?
Get in touch now, get a demo or answer individual questions in a personal conversation.
Discover even more news

Ardeypharm and XO Life: brite™ platform enables digital support for Mutaflor®

XO Life expands internationally - ImpactMonitor™ becomes brite™
